摘要
显著的证据表明富含多酚类的饮食可以防止糖尿病。自先前一些的综述侧重于阐述营养和健康影响的综述被发表,其中就包括2007-2008年间多酚类物质对2型糖尿病的影响,一系列的相关原始文章被发表在这一领域。本文综述了有关膳食多酚和富含多酚类饮食对预防和控制2型糖尿病影响的重大进展,以及在膳食多酚生物活性下的糖尿病调节变化。似乎花青素或富含花青素的食物摄入量与2型糖尿病的风险有关,但其他多酚类与此无关。论述了花青素单独服用比与其他食物混合时更有效。膳食多酚对2型糖尿病的好处可概括为:保护胰腺 β细胞对抗葡萄糖毒性、抗炎和抗氧化作用、抑制 α -淀粉酶或 α-葡糖苷酶,从而减少淀粉的消化,抑制晚期糖化终端产品形成。另外,2型糖尿病也显著受益于膳食纤维,尽管至今进行了为数不多的研究。2型糖尿病如何影响膳食多酚的药理还不清楚。在膳食多酚的药物动力学和生物活性中2型糖尿病调节变化的解读或许可改善植物化学物质的益处和2型糖尿病后续临床结果。
关键词: 益处,膳食多酚,食物,药物动力学,2型糖尿病。
Current Medicinal Chemistry
Title:Dietary Polyphenols and Type 2 Diabetes: Current Insights and Future Perspectives
Volume: 22 Issue: 1
Author(s): J.B. Xiao and P. Hogger
Affiliation:
关键词: 益处,膳食多酚,食物,药物动力学,2型糖尿病。
摘要: Significant evidence suggests that polyphenol-rich diets have the ability to protect against diabetes. Since several previous reviews focused on the nutrition and health effects including type 2 diabetes of polyphenols in 2007-2008, a number of related original publications have been pulished in this field. This review summarizes important advances related to influence of dietary polyphenols and polyphenol-rich diets on preventing and managing type 2 diabetes, as well as diabetes-mediated changes in bioactivities of dietary polyphenols. It appears that anthocyanins or anthocyanin-rich food intake is related to the risk of type 2 diabetes, but there is no association for other polyphenol subclasses. It is discussed that procyanidins are more active when administered individually than when mixed with food. The benefits of dietary polyphenols for type 2 diabetes can be summarized as: protection of pancreatic β-cells against glucose toxicity, anti-inflammatory and antioxidant effects, inhibition of α-amylases or α- glucosidases and thus decrease of starch digestion, and inhibition of advanced glycation end products formation. Moreover, type 2 diabetes also significantly influences the benefits of dietary polyphenols, although there are very limited studies have been conducted so far. How type 2 diabetes impacts the pharmacology of dietary polyphenols is not well understood. Comprehension of type 2 diabetes-mediated changes in pharmacokinetics and bioactivity of dietary polyphenols might lead to improve the benefits of these phytochemicals and subsequent clinical outcomes for type 2 diabetics.
Export Options
About this article
Cite this article as:
J.B. Xiao and Hogger P., Dietary Polyphenols and Type 2 Diabetes: Current Insights and Future Perspectives, Current Medicinal Chemistry 2015; 22 (1) . https://dx.doi.org/10.2174/0929867321666140706130807
DOI https://dx.doi.org/10.2174/0929867321666140706130807 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued) Role of the Renin-Angiotensin System in Gynecologic Cancers
Current Cancer Drug Targets Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology Biological Activities of Three Extracts from Artedia squamata: A Study on Antioxidant and Enzyme Inhibitory Potential
Current Bioactive Compounds Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging The Purinome, a Complex Mix of Drug and Toxicity Targets
Current Topics in Medicinal Chemistry 8-Azapurine Nucleus: A Versatile Scaffold for Different Targets
Mini-Reviews in Medicinal Chemistry To Enhance or to Inhibit Integrin Function in Angiogenesis, that is the Question
Current Angiogenesis (Discontinued) Modulation of Angiotensin II Effects, A Potential Novel Approach to Inflammatory and Immune Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents A New Metabotropic Role for L-type Ca2+ Channels in Vascular Smooth Muscle Contraction
Current Vascular Pharmacology Metabolism in Patients with Rheumatoid Arthritis: Resting Energy Expenditure, Physical Activity and Diet-Induced Thermogenesis. Invited Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Impact of Jugular Vein Valve Function on Cerebral Venous Haemodynamics
Current Neurovascular Research Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction
Current Pharmaceutical Design Adult Changes in Thought Study: Dementia is an Individually Varying Convergent Syndrome with Prevalent Clinically Silent Diseases that may be Modified by Some Commonly Used Therapeutics
Current Alzheimer Research Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Anti-Cancer Agents in Medicinal Chemistry Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets Insulin Resistance-Induced Hypertension and a Role of Perivascular CGRPergic Nerves
Current Protein & Peptide Science Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets